info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
in IN: +91-826-083-6500
Home » Medical Devices »

Orthopedic Biomaterials Market By Type (Ceramics & Bioactive Glasses, Polymers, Calcium Phosphate Cement, Metal, Composites), Application (Orthopedic Implants, Joint Replacement/Reconstruction, Orthobiologics, Viscosupplementation, Bio-resorbable Tissue Fixation) By Geography, Segment revenue estimations, Forecast: 2021-2028

Published On: Jan-2022   |   Base Year: 2000   |   No Of Pages: 140   |   Historical Data: 2015 - 2019   |   Formats: PDF   |   Report ID: 54404553

In 2020, the valuation of the Global Orthopedic Biomaterials Marketwas $ 14.56 billion. It is predicted treach $ 39.11 billion by 2030, representing a CAGR of 10.36 percent throughout the forecasted period.

  

Market Drivers

  • Due tthe increase in geriatric population, more people are likely thave joint disorders, thereby boosting the  overallgrowth of the market. In accordance tthe report published by the United Nations Department of Economic and Social Affairs in 2019, there were 703 Mn individuals aged 65 and over, and the number is expected trise t1.5 Bn by 2050.Moreover, an increase in the number of sports injuries, a rise in the number of cases of trauma resulting from accidents, and an increase in orthopaedic procedures such as joint reconstruction and joint arthroplasty are all driving the orthopaedic biomaterial market's revenue growth.
  • With theintroduction of various Cartilage repair processes, and Spinal cord injury treatments,the growing use of biomaterials in total joint replacement, polymer orthopedic implants, silicone orthopedic implants,Osteosynthesis, Hip Joint Replacements, Spine Implants, Polyurethane (PU) biomaterials, bioabsorbable implants, bisphosphonates and Polyaryletherketonespolymersis driving the overallOrthopedic Biomaterials Market .
  • During the forecasted period, the rising occurences of musculoskeletal ailments and chronic skeletal muscledisorders is expected tpropel the Global Orthopedic Biomaterial Market. According tthe World Health Organization (WHO) in February 2021, around 1.71 Bn individuals worldwide were suffering from musculoskeletal problems. The market is alsgrowing due tan increase in orthopaedic operations such as joint arthroplasty, joint reconstruction, and viscosupplementation.

 

Market Restraint

  • The market's growth has been hampered by restricted reimbursement coverage choices resulting in reduced reimbursements for orthopaedic implants in different countries. Furthermore, the lack of reimbursements has put pressure on manufacturers treduce the pricing of these products, thus limiting the market growth ta great extent.

 

Market Opportunity

  • Several government and non-government programmes are being implemented traise public awareness of orthopaedic biomaterials, which is projected taugment the market expansion throughout the forecasted period. For example, in 2019, the Indian government chose a safe and cost-effective biodegradable orthopaedic implant prototype for commercialization.

 

Market Segmentation

Material Type

  • Ceramics & Bioactive Glasses
  • Polymers
  • Calcium Phosphate Cement
  • Metal
  • Composites

 

Application

  • Orthopedic Implants
  • Joint Replacement/Reconstruction
  • Orthobiologics
  • Viscosupplementation
  • Bio-resorbable Tissue Fixation

 

By Region

North America

  • U.S.
  • Canada
  • Mexico

 

Europe

  • Germany
  • France
  • Italy
  • Switzerland
  • UK
  • Rest of Europe

 

Asia-Pacific

  • Japan
  • China
  • India
  • Rest of Asia-Pacific

 

LAMEA

  • Brazil
  • Israel
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

 

Due tgrowing acceptance of ceramics in the restoration of hard tissues in various procedures, the ceramics & bioactive glass sector had the greatest market share in 2020. During the forecasted period, the segment is expected tbe driven by an increase in minimally invasive spine surgery using glass-ceramic & bioactive glasses, an increase in interbody fusion procedures, and the rise in usage of synthetic cages or Bone Allograftsfor spine surgeries.The polymer segment, on the other hand, is expected tgrow at the fastest rate throughout the anticipated period, owing tthe widespread usage of polymers as bone cement and load bearing surfaces in joint arthroplasties.

Due tthe high procedural volume of joint replacements, the ‘joint replacements testing’ sector dominated the market in 2020. From 2012 t2016, the procedural volume of joint replacement in the United States increased by 57.7%, according tthe American Joint Replacement Registry. The number of procedures conducted increased from 45,517 in 2012 t281,746 in 2016.

In 2020, North Americaheld the leading orthopedic biomaterials market share in 2020. The rising prevalenceof the patients requiring knee replacement, reconstruction, and other joint-related orthopaedic surgeries are the primary reasonsfor this growth. The market is anticipated tgrow in response tthe rapid adoption of sophisticated products for bone void filling and implant load-bearing purposes. 

With a CAGR of 11.8 percent over the projected period, Asia Pacific is expected tbe the fastest-growing regional market. The increased frequency of bone degenerative illnesses and bone disorders in low- and middle-income nations are one of the major reasonsfor the growth of thisregional market. Furthermore, rising healthcare expenditures combined with the improved healthcare infrastructures are likely tbe a high-impact revenue driver in this region's market.

 

Competitive Analysis

List of the Key Market Players are as follows:

  • B. Braun Melsungen AG, CONMED Corp.
  • Evonik Industries AG, 
  • Medtronic Plc.
  • Smith & Nephew Plc., Stryker Corp.
  • Victrex Plc.
  • Zimmer Biomet Holdings Inc.
  • Globus Medical
  • Heraeus Holding GmbH
  • Exactech Inc.
  • Collagen Matrix Inc.
  • InvibiLtd.
  • DePuy Synthes

 

Recent Developments

  • In November 2019, Stryker, an American Fortune 500 medical equipment firm, reached a definitive agreement tbuy Wright Medical for $5.4 Bn. This acquisition will help tsustain and enhance Stryker's orthopaedic segment, as well as give Wright Medical's extremities and biologics segmenta greater level of exposure.
  • In November 2019, DiFusion received FDA clearance for launching the Xiphos-ZF spinal interbody device, the first spinal implant made from the biomaterial Zfuze.

Frequently Asked Question About This Report

N/A

 

1.   Introduction

       1.1.  Study Objective

       1.2.  Market Definition        

       1.3.  Study Scope

              1.3.1. Markets Covered

              1.3.2. Geographic Scope

              1.3.3. Years Considered

              1.3.4. Stakeholders

2.   Research Methodology

       2.1.  Data Procurement

       2.2.  Paid Database

              2.2.1. Secondary Data

                     2.2.1.1. Key Secondary sources

              2.2.2. Primary Data

                     2.2.2.1 Primary sources

                     2.2.2.2. Key industry insights

                     2.2.2.3. Primary interviews with experts

                     2.2.2.4. Key primary respondent list

       2.3.  Market Size Estimation

       2.4.  Bottom-Up and Top-Down Approaches

              2.4.1.       Bottom-Up Approach

                     2.4.1.1.            Approach for arriving at market size by bottom-up analysis

              2.4.2.       Top-Down Approach

                     2.4.2.1.            Approach for Capturing Market Size by Top-Down Analysis

       2.5.  Market Breakdown and Data Triangulation

       2.6.  Research Methodology

       2.7.  Risk Assessment

3.  Executive Summary

       3.1   Orthopedic Biomaterials Market: Post-Covid-19

              3.1.1        Actual Scenario

              3.1.2        Pessimistic Scenario

              3.1.3        Optimistic Scenario

              3.1.4        Market Summary

4. Industry Outlook

       4.1   Market Snapshot

       4.2   Global Orthopedic Biomaterials Market

              4.2.1        Global Orthopedic Biomaterials Market, 2020 – 2028 (USD Million)

       4.3   Regional Business Analysis

              4.3.1        Global Orthopedic Biomaterials Market, by Region, 2020 - 2028 (USD Million)

       4.4   Material Type Business Analysis

              4.4.1        Global Orthopedic Biomaterials Market,  By Material Type, 2020 - 2028 (USD Million)

       4.5   Application Business Analysis

              4.5.1        Global Orthopedic Biomaterials Market, By Application, 2020 - 2028 (USD Million)

       4.6   Value Chain Analysis

       4.7   Market Variable Analysis

              4.7.1        Market Drivers Analysis

              4.7.2        Market Restraints Analysis

       4.8   Business Environment Analysis Tool

              4.8.1        Orthopedic Biomaterials Market PEST analysis

              4.8.2        Orthopedic Biomaterials Market Porter’s analysis

       4.9   Penetration & Growth Prospect Mapping

5. Market Dynamics

       5.1.  Introduction

       5.2.  Market Dynamics

              5.2.1.       Drivers

              5.2.2.       Restraints

              5.2.3.       Opportunities

              5.2.4.       Challenges

       5.3.  Impact of Covid-19 On Orthopedic Biomaterials Market

       5.4.  Value Chain Analysis

       5.5.  Ecosystem

       5.6.  Patent Analysis

       5.7.  Trade Analysis

       5.8.  Tariff Analysis

       5.9.  Case Study Analysis

5.10.      Porter’s Five Forces Analysis

              5.10.1      Threat of New Entrants

              5.10.2      Threat of Substitutes

              5.10.3      Bargaining Power of Buyers

              5.10.4      Bargaining Power of Suppliers

              5.10.5      Degree of Competition

       5.11.               Technology Analysis

              5.11.1.     Trends in Technology (2014-2020)

              5.11.2.     Trends in Technology (2021-2028)

       5.12.               Pricing Analysis

              5.12.1.     Average Price Trend Analysis (By region, By Countries)

6. Competitive & Vendor Landscape

       6.1.  Company Market Share Analysis

       6.2.  Manufacturers Orthopedic Biomaterials Manufacturing Sites, Area Served, Material Type

       6.3.  Orthopedic Biomaterials Market Competitive Situation and Trends

       6.4.  Manufacturers Mergers & Acquisitions, Expansion Plans

7. Global Orthopedic Biomaterials Market:  By Material Type Segment Analysis

       7.1.  Introduction

       7.2.  Sales Volume & Revenue Analysis (2020-2028)

       7.3.  Ceramics & Bioactive Glasses

              7.3.1. Ceramics & Bioactive Glasses market, 2020 - 2028 (USD Million)

       7.4.  Polymers

              7.4.1. Polymers market, 2020 - 2028 (USD Million)

      7.5 Calcium Phosphate Cement

             7.5.1 Calcium Phosphate Cement market, 2020 - 2028 (USD Million)

      7.6  Metal

             7.6.1 Metal market, 2020 - 2028 (USD Million)

      7.7  Composites

            7.7.1 Composites market, 2020 - 2028 (USD Million)

8. Global Orthopedic Biomaterials Market: By Application Segment Analysis

       8.1. Introduction

       8.2. Sales Volume & Revenue Analysis (2020-2028)

       8.3. Orthopedic Implants

              8.3.1. Orthopedic Implants market, 2020 - 2028 (USD Million)

       8.4. Joint Replacement/Reconstruction

              8.4.1. Joint Replacement/Reconstruction market, 2020 - 2028 (USD Million)

       8.5  Orthobiologics

              8.5.1 Orthobiologics market, 2020 - 2028 (USD Million)

       8.6 Viscosupplementation

              8.6.1 Viscosupplementation market, 2020 - 2028 (USD Million)

       8.7 Bio-resorbable Tissue Fixation

              8.7.1 Bio-resorbable Tissue Fixation market, 2020 - 2028 (USD Million)

       8.11 Others

              8.11.1 Others market, 2020 - 2028 (USD Million)

 

9. Global Orthopedic Biomaterials Market: Regional Outlook

       9.1   North America

              9.1.1.       North America Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

              9.1.4.       North America Orthopedic Biomaterials Market, By Application, 2020 - 2028 (USD Million)

 

              9.1.5.       North America Orthopedic Biomaterials Market, by Country, 2020 - 2028 (USD Million)

9.1.4.1. U.S.

                     9.1.4.1.1.         U.S. Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

    9.1.4.2.      Canada

                     9.1.4.2.1.         Canada Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

                     9.1.4.2.2.         Canada Orthopedic Biomaterials Market, By Region, 2020 - 2028 (USD Million)

                     9.1.4.2.3.         Canada Orthopedic Biomaterials Market, by Applications, 2020 - 2028 (USD Million)

9.2.         Europe

              9.2.1.       Europe Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

              9.2.2.       Europe Orthopedic Biomaterials Market, by  By Application, 2020 - 2028 (USD Million)

              9.2.5.       Europe Orthopedic Biomaterials Market, by country, 2020 - 2028 (USD Million)

    9.2.4.1    U.K.

                     9.2.4.1.1.         U.K. Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

                     9.2.4.1.2.         U.K. Orthopedic Biomaterials Market, By Applications, 2020 - 2028 (USD Million)

                     9.2.4.1.3.         U.K. Orthopedic Biomaterials Market, by Region, 2020 - 2028 (USD Million)

   9.2.4.2.              Germany

                     9.2.4.2.1.         Germany Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

                     9.2.4.2.2.         Germany Orthopedic Biomaterials Market, By Application, 2020 - 2028 (USD Million)

                     9.2.4.2.3.         Germany Orthopedic Biomaterials Market, by Region, 2020 - 2028 (USD Million)

   9.2.4.3.              France

                     9.2.4.3.1.         France Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

                     9.2.4.3.2.         France Orthopedic Biomaterials Market, By Region, 2020 - 2028 (USD Million)

                     9.2.4.3.3.         France Orthopedic Biomaterials Market, by Application, 2020 - 2028 (USD Million)

    9.2.4.4.             Rest of Europe

                     9.2.4.4.1.         Rest of Europe Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

                     9.2.4.4.2.         Rest of Europe Orthopedic Biomaterials Market, By Region, 2020 - 2028 (USD Million)

                     9.2.4.4.3.         Rest of Europe Orthopedic Biomaterials Market, by Application, 2020 - 2028 (USD Million)

       9.3.  Asia Pacific

              9.3.1.       Asia Pacific Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

              9.3.2.       Asia Pacific Orthopedic Biomaterials Market, By Application, 2020 - 2028 (USD Million)

              9.3.5.       Asia Pacific Orthopedic Biomaterials Market, by country, 2020 - 2028 (USD Million)

   9.3.4.1.              China

                     9.3.4.1.1.         China Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

                     9.3.4.1.2.         China Orthopedic Biomaterials Market, By Region, 2020 - 2028 (USD Million)

                     9.3.4.1.3.         China Orthopedic Biomaterials Market, by Application, 2020 - 2028 (USD Million)

   9.3.4.2.              India

                     9.3.4.2.1.         India Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

                     9.3.4.2.2.         India Orthopedic Biomaterials Market, By Region, 2020 - 2028 (USD Million)

                     9.3.4.2.3.         India Orthopedic Biomaterials Market, by Application, 2020 - 2028 (USD Million)

   9.3.4.3.              Japan

                     9.3.4.3.1.         Japan Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

                     9.3.4.3.3.         Japan Orthopedic Biomaterials Market, by Application, 2020 - 2028 (USD Million)

   9.3.4.4.              South Korea

                     9.3.4.4.1.         South Korea Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

                     9.3.4.4.3.         South Korea Orthopedic Biomaterials Market, by Application, 2020 - 2028 (USD Million)

9.3.4.5.             Rest of ASIA PACIFIC

                     9.3.4.5.1.         Rest of ASIA PACIFIC Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

                     9.3.4.5.3.         Rest of ASIA PACIFIC Orthopedic Biomaterials Market, by Application, 2020 - 2028 (USD Million)

       9.4.  Latin America

              9.4.1.       Latin America Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

              9.4.3.       Latin America Orthopedic Biomaterials Market, by Application, 2020 - 2028 (USD Million)

              9.4.4.       Latin America Orthopedic Biomaterials Market, by country, 2020 - 2028 (USD Million)

9.4.4.1. Brazil

                     9.4.4.1.1.         Brazil Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

                     9.4.4.1.3.         Brazil Orthopedic Biomaterials Market, by Application, 2020 - 2028 (USD Million)

9.4.4.2. Mexico

                     9.4.4.2.1.         Mexico Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

                     9.4.4.2.3.         Mexico Orthopedic Biomaterials Market, by Application, 2020 - 2028 (USD Million)

  9.4.4.3.               Rest of the Latin America

                     9.4.4.3.1.         Rest of the Latin America Orthopedic Biomaterials Market, By Material Type, 2020 - 2028 (USD Million)

                     9.4.4.3.3.         Rest of the Latin America Orthopedic Biomaterials Market, by Application, 2020 - 2028 (USD Million)

10. Competitive Landscape

       10.1 B. Braun Melsungen AG, CONMED Corp.

              10.1.1.     Company overview

              10.1.2.     Financial performance

              10.1.3.     Product Portfolio Analysis

              10.1.4.     Business Strategy & Recent Development

       10.2. Evonik Industries AG.

              10.2.1.     Company overview

              10.2.2.     Financial performance

              10.2.3.     Product Portfolio Analysis

              10.2.4.     Business Strategy & Recent Development

       10.3. Medtronic Plc. 

              10.3.1.     Company overview

              10.3.2.     Financial performance

              10.3.3.     Product Portfolio Analysis

              10.3.4.     Business Strategy & Recent Development

       10.4. Smith & Nephew Plc., Stryker Corp.

              10.4.1.     Company overview

              10.4.2.     Financial performance

              10.4.3.     Product Portfolio Analysis

              10.4.4.     Business Strategy & Recent Development

       10.5. Victrex Plc.

              10.5.1.     Company overview

              10.5.2.     Financial performance

              10.5.3.     Product Portfolio Analysis

              10.5.4.     Business Strategy & Recent Development

       10.6. Zimmer Biomet Holdings Inc.

              10.6.1.     Company overview

              10.6.2.     Financial performance

              10.6.3.     Product Portfolio Analysis

              10.6.4.     Business Strategy & Recent Development

       10.7. Globus Medical.

              10.7.1.     Company overview

              10.7.2.     Financial performance

              10.7.3.     Product Portfolio Analysis

              10.7.4.     Business Strategy & Recent Development

       10.8. Heraeus Holding GmbH.

              10.8.1.     Company overview

              10.8.2.     Financial performance

              10.8.3.     Product Portfolio Analysis

              10.8.4.     Business Strategy & Recent Development

       10.9. Exactech Inc.

              10.9.1.     Company overview

              10.9.2.     Financial performance

              10.9.3.     Product Portfolio Analysis

              10.9.4.     Business Strategy & Recent Development

       10.10. Collagen Matrix Inc.

              10.10.1.  Company overview

              10.10.2.  Financial performance

              10.10.3.  Product Portfolio Analysis

              10.10.4.  Business Strategy & Recent Development

       10.11. Invibio Ltd.

              10.11.1.  Company overview

              10.11.2.  Financial performance

              10.11.3.  Product Portfolio Analysis

              10.11.4.  Business Strategy & Recent Development

       10.12. DePuy Synthes.

              10.12.1.  Company overview

              10.12.2.  Financial performance

              10.12.3.  Product Portfolio Analysis

              10.12.4.  Business Strategy & Recent Development

 

List of Tables (53 Tables)

TABLE 1.  Orthopedic Biomaterials Market,  By Material Type, 2020-2028 (USD Million)

TABLE 2.  Orthopedic Biomaterials Market  FOR Ceramics & Bioactive Glasses, BY REGION, 2020-2028 (USD Million)

TABLE 3.  Orthopedic Biomaterials Market FOR Polymers, BY REGION, 2020-2028 (USD Million)

TABLE 4.  Orthopedic Biomaterials Market FOR Calcium Phosphate Cement, BY REGION, 2020-2028 (USD Million)

TABLE 5.  Orthopedic Biomaterials Market FOR Metal, BY REGION, 2020-2028 (USD Million)

TABLE 6.  Orthopedic Biomaterials Market FOR Composites, BY REGION, 2020-2028 (USD Million)

TABLE 7. Orthopedic Biomaterials Market, BY APPLICATION, 2020-2028 (USD Million)

TABLE 8. Orthopedic Biomaterials Market FOR Orthopedic Implants, BY REGION, 2020-2028 (USD Million)

TABLE 9. Orthopedic Biomaterials Market FOR Joint Replacement/Reconstruction, BY REGION, 2020-2028 (USD Million)

TABLE 10. Orthopedic Biomaterials Market FOR Orthobiologics, BY REGION, 2020-2028 (USD Million)

TABLE 11. Orthopedic Biomaterials Market FOR Viscosupplementation, BY REGION, 2020-2028 (USD Million)

TABLE 12. Orthopedic Biomaterials Market FOR Bio-resorbable Tissue Fixation, BY REGION, 2020-2028 (USD Million)

TABLE 13. Orthopedic Biomaterials Market FOR Others, BY REGION, 2020-2028 (USD Million)

TABLE 14. Orthopedic Biomaterials Market, BY REGION, 2020-2028 (USD Million)

TABLE 15. NORTH AMERICA Orthopedic Biomaterials Market, BY COUNTRY, 2020-2028 (USD Million)

TABLE 16. NORTH AMERICA Orthopedic Biomaterials Market, BY Applications, 2020-2028 (USD Million)

TABLE 17. NORTH AMERICA Orthopedic Biomaterials Market,  By Material Type, 2020-2028 (USD Million)

TABLE 18. NORTH AMERICA Orthopedic Biomaterials Market, BY APPLICATION, 2020-2028 (USD Million)

TABLE 19. EUROPE Orthopedic Biomaterials Market, BY COUNTRY, 2020-2028 (USD Million)

TABLE 20. EUROPE Orthopedic Biomaterials Market,  By Material Type, 2020-2028 (USD Million)

TABLE 21. EUROPE Orthopedic Biomaterials Market, BY APPLICATION, 2020-2028 (USD Million)

TABLE 22. ASIA-PACIFIC Orthopedic Biomaterials Market, BY COUNTRY, 2020-2028 (USD Million)

TABLE 23. ASIA-PACIFIC Orthopedic Biomaterials Market,  By Material Type, 2020-2028 (USD Million)

TABLE 24. ASIA-PACIFIC Orthopedic Biomaterials Market, BY APPLICATION, 2020-2028 (USD Million)

TABLE 25. LAMEA Orthopedic Biomaterials Market, BY COUNTRY, 2020-2028 (USD Million)

TABLE 26. LAMEA Orthopedic Biomaterials Market,  By Material Type, 2020-2028 (USD Million)

TABLE 27. LAMEA Orthopedic Biomaterials Market, BY APPLICATION, 2020-2028 (USD Million)

TABLE 28. B. Braun Melsungen AG, CONMED Corp: COMPANY SNAPSHOT

TABLE 29. B. Braun Melsungen AG, CONMED Corp: OPERATING SEGMENTS

TABLE 30. Evonik Industries AG: COMPANY SNAPSHOT

TABLE 31. Evonik Industries AG: OPERATING SEGMENTS

TABLE 32. Medtronic Plc: COMPANY SNAPSHOT

TABLE 33. Medtronic Plc: OPERATING SEGMENTS

TABLE 34. Smith & Nephew Plc., Stryker Corp: COMPANY SNAPSHOT

TABLE 35. Smith & Nephew Plc., Stryker Corp: OPERATING SEGMENTS

TABLE 36. SCR-Sibelco: COMPANY SNAPSHOT

TABLE 37. SCR-Sibelco: OPERATING SEGMENTS

TABLE 38 Victrex Plc: COMPANY SNAPSHOT

TABLE 39. Victrex Plc: OPERATING SEGMENTS

TABLE 40. Zimmer Biomet Holdings Inc: COMPANY SNAPSHOT

TABLE 41. Zimmer Biomet Holdings Inc: OPERATING SEGMENTS

TABLE 42. Globus Medical: COMPANY SNAPSHOT

TABLE 43. Globus Medical: OPERATING SEGMENTS

TABLE 44 Heraeus Holding GmbH: COMPANY SNAPSHOT

TABLE 45. Heraeus Holding GmbH: OPERATING SEGMENTS

TABLE 46. Exactech Inc: COMPANY SNAPSHOT

TABLE 47. Exactech Inc: OPERATING SEGMENTS

TABLE 48. Collagen Matrix Inc: COMPANY SNAPSHOT

TABLE 49. Collagen Matrix Inc: OPERATING SEGMENTS

TABLE 50. Invibio Ltd: COMPANY SNAPSHOT

TABLE 51. Invibio Ltd: OPERATING SEGMENTS

TABLE 52. DePuy Synthes: COMPANY SNAPSHOT

TABLE 53. DePuy Synthes: OPERATING SEGMENTS

 

List of Figures (20 Figures)

Figure 1 Orthopedic Biomaterials Market: Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries: Orthopedic Biomaterials Market

Figure 4 Research Methodology: Hypothesis Building

Figure 5 Orthopedic Biomaterials Market: Product-Based Estimation

Figure 6 Top 12 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2020

Figure 8 Import Data for Orthopedic Biomaterials, By Country, 2016–2020 (USD Thousand)

Figure 9 Export Data for Orthopedic Biomaterials, By Country, 2016–2020 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11 Orthopedic Biomaterials Market, By Applications, 2019 vs. 2025 (USD Million)

Figure 12 Orthopedic Biomaterials Market Share, By Material Type, 2019 vs. 2025

Figure 13 Geographical Snapshot of the Orthopedic Biomaterials Market

Figure 14 Ceramics & Bioactive Glasses to Witness Higher CAGR in Orthopedic Biomaterials Market for Material Type Segment during Forecast Period.

Figure 15 Joint Replacement to Witness Higher CAGR in Orthopedic Biomaterials Market for Application Segment during Forecast Period.

Figure 16 North American Accounted for the Largest Share of the Orthopedic Biomaterials Market, By Regional Basis, in 2019

Figure 17 Orthopedic Biomaterials Market: Drivers, Restraints, Opportunities, and Challenges

Figure 18 North America: Orthopedic Biomaterials Market Snapshot

Figure 19 Asia Pacific: Orthopedic Biomaterials Market Snapshot

Figure 20 Vendor Dive: Evaluation Overview